Role of thromboxane in retinal microvascular degeneration in oxygen-induced retinopathy

Journal of Applied Physiology

Volumn 90, Issue 6, 2001, Pages 2279-2288

  Beauchamp, Martin H ^a   Martinez Bermudez, Ana Katherine ^a,b   Gobeil Jr , Fernand ^a   Marrache, Anne Marilise ^a,b   Hou, Xin ^a   Speranza, Giovanna ^a,b   Abran, Daniel ^a   Quiniou, Christiane ^a   Lachapelle, Pierre ^b   Roberts II, Jackson ^c   Almazan, Guillermina ^b   Varma, Daya R ^b   Chemtob, Sylvain ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Apoptosis; Endothelium; Necrosis; Peroxidation; Retina

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3 METHYL 2 (3 PYRIDYL) 1 INDOLEOCTANOIC ACID; 7 [3 [3 HYDROXY 4 (4 IODOPHENOXY) 1 BUTENYL] 7 OXABICYCLO[2.2.1]HEPTAN 2 YL] 5 HEPTENOIC ACID; 8 ISOPROSTAGLANDIN F2; CGS 22652; OXYGEN; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; THROMBOXANE A2 RECEPTOR STIMULATING AGENT; THROMBOXANE B2; THROMBOXANE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; HYPEROXIA; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PEROXIDATION; PRIORITY JOURNAL; RAT; RETINA BLOOD VESSEL; RETINA DEGENERATION; RETINOPATHY; RETROLENTAL FIBROPLASIA; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 0034999487     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.2001.90.6.2279     Document Type: Article

References (67)

1. Abran D, Varma DR, Li DY, and Chemtob S. Reduced responses of retinal vessels of the newborn pig to prostaglandins but not to thromboxane. Can J Physiol Pharmacol 72: 168-173, 1994.
2. Allain CC, Henson CP, Nadel MK, and Knoblesdorff AJ. Rapid single-step kinetic colorimetric assay for lactate dehydrogenase in serum. Clin Chem 19: 223-227, 1993.
3. Ambler J, Butler KD, Ku EC, Maguire ED, Smith JR, and Wallis RB. CGS 12970: a novel, long acting thromboxane synthetase inhibitor. Br J Pharmacol 86: 497-504, 1985.
4. 2: its generation and role in platelet activation. Prog Lipid Res 28: 273-301, 1989.
5. 2. J Biol Chem 274: 35562-35570, 1999.
6. Ashton N. Oxygen and the growth and development of retinal vessels. In vivo and in vitro studies. The XX Francis I Proctor Lecture. Am J Ophthalmol 62: 412-435, 1966.
7. Ashton N. Some aspects of the comparative pathology of oxygen toxicity in the retina. Donders lecture, 1967. Br J Ophthalmol 52: 505-531, 1968.
8. Ashton N and Blach R. Studies in developing retinal vessels. VIII. Effect of oxygen on the vessels of the ratling. Br J Ophthalmol 45: 321-340, 1961.
9. Auge N, Pieraggi MT, Thiers JC, Negre-Salvayre A, and Salvayre R. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth muscle cells. Biochem J 309: 1015-1020, 1995.
10. 2 mapping. Invest Ophthalmol Vis Sci 37: 2089-2098, 1996.
11. Bloodworth JM Jr, Gutgesell HP Jr, and Engerman RL. Retinal vasculature of the pig. Light and electron microscope studies. Exp Eye Res 4: 174-178, 1965.
12. Bowes J, Piper J, and Thiemermann C. Inhibitors of the activity of poly (ADP-ribose) synthase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts. Br J Pharmacol 124: 1760-1766, 1998.
13. Chakraborti T, Das S, Mondal M, Roychoudhury S, and Chakraborti S. Oxidant, mitochondria and calcium: an overview. Cell Signal 11: 77-85, 1999.
14. Chan-Ling T and Stone J. Retinopathy of prematurity: origins in the architecture of the retina. Prog Retin Eye Res 12: 155-178, 1992.
15. Chemtob S, Hardy P, Abran D, Li DY, Peri K, Cuzzani O, and Varma DR. Peroxide-cyclooxygenase interactions in post-asphyxial changes in retinal and choroidal hemodynamics. J Appl Physiol 78: 2039-2046, 1995.
16. 2 synthase properties. Cardiovasc Drug Rev 10: 379-391, 1992.
17. D'amore PA and Sweet E. Effects of hyperoxia on microvascular cells in vitro. In Vitro Cell Dev Biol 23: 123-128, 1987.
18. 2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res 59: 4574-4577, 1999.
19. Davies P, Smith BT, Maddalo FB, Langleben D, Tobias D, Fujiwara K, and Reid L. Characteristics of lung pericytes in culture including their growth inhibition by endothelial substrate. Microvasc Res 33: 300-314, 1987.
20. De la Cruz JP, Moreno A, Ruiz-Ruiz MI, Garcia-Campos J, and Sanchez de la Cuesta F. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats. Eur J Pharmacol 360: 37-42, 1998.
21. 2 biosynthesis in human disease. Fed Proc 46: 154-158, 1987.
22. Ford-Hutchinson AW, Girard Y, Lord A, Jones TR, Cirino M, Evans JF, Gillard J, Hamel P, Leveille C, Masson P, et al. The pharmacology of L-670,596, a potent and selective thromboxane/prostaglandin endoperoxide receptor antagonist. Can J Physiol Pharmacol 67: 989-993, 1989.
23. Gardner AM, Xu FH, Fady C, Jacoby FJ, Duffey DC, Tu Y, and Lichtenstein A. Apoptotic vs. nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic Biol Med 22: 73-83, 1997.
24. 2 in reperfusion injury. Proc Soc Exp Biol Med 188: 504-508, 1988.
25. Halks-Miller M, Henderson M, and Eng LF. Alpha tocopherol decreases lipid peroxidation, neural necrosis, and reactive gliosis in reaggregate cultures of fetal rat brain. J Neuropathol Exp Neurol 45: 471-484, 1986.
26. 2 receptor in cultured vascular endothelial cells of rat aorta. Biochem Biophys Res Commun 151: 1352-1357, 1988.
27. Hannun YA. Functions of ceramide in coordinating cellular responses to stress. Science 274: 1855-1859, 1996.
28. Henkind P and De Oliveira LF. Development of retinal vessels in the rat. Invest Ophthalmol 6: 520-530, 1967.
29. 2α) in immature pig periventricular brain microvessels. Stroke 31: 516-524, 2000.
30. Iijima T, Sawa H, Shiokawa Y, Saito I, Ishii H, Nakamura Z, and Sankawa H. Thromboxane synthetase inhibitor ameliorates delayed neuronal death in the CA1 subfield of the hippocampus after transient global ischemia in gerbils. J Neurosurg Anesthesiol 8: 237-242, 1996.
31. 2 receptor blockade suppresses intercellular adhesion molecule-1 expression by stimulated vascular endothelial cells. Eur J Pharmacol 312: 367-377, 1996.
32. 2 receptors on human endothelial cells. Circ Res 72: 958-965, 1993.
33. 2 receptor from rat astrocytes. Biochim Biophys Acta 1265: 220-223, 1995.
34. Kondo T, Kinouchi H, Kawase M, and Yoshimoto T. Differential release of hydrogen peroxide between astroglial cells and endothelial cells following hypoxia/reoxygenation. Neurosci Lett 215: 103-106, 1996.
35. Lachapelle P, Dembinska O, Rojas LM, Benoit J, Almazan G, and Chemtob S. Persistent functional and structural retinal anomalies in newborn rats exposed to hyperoxia. Can J Physiol Pharmacol 77: 48-55, 1999.
36. 2α on retinal vessels. Am J Physiol Regulatory Integrative Comp Physiol 274: R1406-R1416, 1998.
37. Lemasters JJ. Mechanisms of hepatic toxicity. V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol Gastrointest Liver Physiol 276: G1-G6, 1999.
38. Loo DT and Rillema JR. Measurement of cell death. Methods Cell Biol 57: 251-264, 1998.
39. Lutty GA and McLeod DS. A new technique for visualization of the human retinal vasculature. Arch Ophthalmol 110: 267-276, 1992.
40. 2 in radical production during ischemia and reperfusion of the rat brain. Brain Res 709: 296-302, 1996.
41. McGahon AJ, Martin SJ, Bissonnette RP, Mahboubi A, Shi Y, Mogil RJ, Nishioka WK, and Green DR. The end of the (cell) line: methods for the study of apoptosis in vitro. Methods Cell Biol 46: 153-185, 1995.
42. McLeod DS, Brownstein R, and Lutty GA. Vaso-obliteration in the canine model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 37: 300-311, 1996.
43. McLeod DS, Crone SN, and Lutty GA. Vasoproliferation in the neonatal dog model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 37: 1322-1333, 1996.
44. Ment LR, Stewart WB, Petroff OA, and Duncan CC. Thromboxane synthesis inhibitor in a beagle pup model of perinatal asphyxia. Stroke 20: 809-814, 1989.
45. Moore A, Donahue CJ, Bauer KD, and Mather JP. Simultaneous measurement of cell cycle and apoptotic cell death. Methods Cell Biol 57: 265-278, 1998.
46. Muruganandam A, Herx LM, Monette R, Durkin JP, and Stanimirovic DB. Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood-brain barrier. FASEB J 11: 1187-1197, 1997.
47. Nandgaonkar BN, Rotschild T, Yu K, and Higgins RD. Indomethacin improves oxygen-induced retinopathy in the mouse. Pediatr Res 46: 184-188, 1999.
48. Niesman MR, Johnson KA, and Penn JS. Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity. Neurochem Res 22: 597-605, 1997.
49. 2+-dependent mechanisms of cytotoxicity and programmed cell death. Toxicol Lett 64-65: 357-364, 1992.
50. Parys-Van Ginderdeuren R, Malcolm D, Varma DR, Aranda JV, and Chemtob S. Dissociation between prostaglandin levels and blood flow to the retina and choroid in the newborn pig after nonsteroidal antiinflammatory drugs. Invest Ophthalmol Vis Sci 33: 3378-3384, 1992.
51. Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 330: 1287-1294, 1994.
52. Penn JS, Tolman BL, and Bullard LE. Effect of a water-soluble vitamin E analog, trolox C, on retinal vascular development in an animal model of retinopathy of prematurity. Free Radic Biol Med 22: 977-984, 1997.
53. Raju TN, Langenberg P, Bhutani V, and Quinn GE. Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials. J Pediatr 131: 844-850, 1997.
54. Reynaud X and Dorey CK. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest Ophthalmol Vis Sci 35: 3169-3177, 1994.
55. Reynaud X, Hansen RM, and Fulton AB. Effect of prior oxygen exposure on the electroretinographic responses of infant rats. Invest Ophthalmol Vis Sci 36: 2071-2079, 1995.
56. Robert A, Nezamis JE, Lancaster C, and Hanchar AJ. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology 77: 433-443, 1979.
57. Roberts LJ 2nd and Morrow JD. The generation and actions of isoprostanes. Biochim Biophys Acta 1345: 121-135, 1997.
58. Siesjo BK, Agardh CD, and Bengtsson F. Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1: 165-221, 1989.
59. Simm A, Bertsch G, Frank H, Zimmermann U, and Hoppe J. Cell of AKR-2B fibroblasts after serum removal: a process between apoptosis and necrosis. J Cell Sci 110: 819-828, 1997.
60. Sisson T. The effect of light and various concentrations of oxygen on the retina of the newborn pig. In: Retinopathy of Prematurity Conference Syllabus. Washington, DC: 1981, p. 581-599.
61. 2 into the brain extracellular space after 15 min of complete global ischemia in the presence and absence of cyclooxygenase inhibition. J Cereb Blood Flow Metab 8: 790-798, 1988.
62. Tasman W. Vitreoretinal changes in cicatricial retrolental fibroplasia. Trans Am Ophthalmol Soc 68: 548-594, 1970.
63. Thorin E and Shreeve SM. Heterogeneity of vascular endothelial cells in normal and disease states. Pharmacol Ther 78: 155-166, 1998.
64. Trump BF and Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J 9: 219-228, 1995.
65. 2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J Exp Med 178: 1825-1830, 1990.
66. 2-mediated cytoprotection in renal epithelial cells: evidence for a pharmacologically distinct receptor. Am J Physiol Renal Physiol 273: F507-F515, 1997.
67. Zaks TZ, Chappell DB, Rosenberg SA, and Restifo NP. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition. J Immunol 162: 3273-3279, 1999.